#news #biotech Metacrine shares halved as NASH program nixed on mixed bag data and early safety issue

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Metacrine shares halved as NASH program nixed on mixed bag data and early safety issue .Metacrine shares halved as NASH program nixed on mixed bag data and early safety issue
badams
Fri, 10/22/2021 – 06:32

from FierceBiotech: Biotech https://ift.tt/3vDcXEA